Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 30,100 shares, a decrease of 78.3% from the December 31st total of 138,600 shares. Approximately 2.6% of the company’s stock are short sold. Based on […]
LONDON - Virax Biolabs Group Limited , an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced a strategic collaboration.
Virax Biolabs Group Limited announced a strategic collaboration with the University of Manchester and the Northern Care Alliance Foundation Trust, who have a track record in working together to.
Virax Biolabs Group (VRAX) Enters Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.